← Open Payments lookup

STEVEN SUGG: Open Payments

NPI 1750308193 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,281 in 58 payments from 14 companies in 2025. Trend: 2023 $1,392 · 2024 $1,613 · 2025 $1,281

Food & beverage: $1,281
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.10$278
ABBVIE INC.19$228
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$207
Vanda Pharmaceuticals Inc.4$135
Axsome Therapeutics, Inc.3$89
Takeda Pharmaceuticals U.S.A., Inc.3$85
Supernus Pharmaceuticals, Inc.3$64
Otsuka Pharmaceutical Development & Commercialization, Inc.2$45
Janssen Pharmaceuticals, Inc2$41
Neurocrine BioSciences, Inc.1$26

Products named: REXULTI, VRAYLAR, CAPLYTA, FANAPT, Auvelity, TRINTELLIX, Qelbree, SPRAVATO.

Industry payments across AL — which companies pay providers there.